Denmark Introduces First Confidential Pricing Framework For Primary Care Medicines

 
• By Francesca Bruce
  
Confidential pricing for some primary care medicines in Denmark could improve access to innovative drugs. (Shutterstock)

More from Pricing Debate

More from Market Access